首页> 外文期刊>外科学(英文) >COVID 19 Diagnostic Tests: A Study of 12,270 Patients to Determine Which Test Offers the Most Beneficial Results
【24h】

COVID 19 Diagnostic Tests: A Study of 12,270 Patients to Determine Which Test Offers the Most Beneficial Results

机译:COVID 19诊断测试:一项针对12,270名患者的研究,以确定哪种测试可提供最有益的结果

获取原文
获取原文并翻译 | 示例
       

摘要

COVID 19 has caused capitulation from healthcare entities all over the world. First described in Hubei, China, the virus has spread to 185 countries, showing little signs of eradication or eradication. There does not exist a medical treatment regimen or a vaccine to address COVID 19 definitively. The best response, to date, has been early diagnosis and immediate isolation or quarantine of the patient, with supportive care. As medical institutions all around the world struggle to keep up with this pandemic, there is not a consensus amongst medical professionals in the rapid diagnosis of this disease entity. Purpose: The purpose of our study was to review the literature and establish a test, or tests, that would aid the clinician in attaining a swift, yet accurate diagnosis. Methods: We searched PubMed and Google scholar and reviewed 32 articles. Keyword searches consisted of COVID 19, pandemic, diagnoses, diagnostic testing, pandemic amongst others. We compared the data obtained from these studies in an effort to find the best diagnostic test. Results: There were a total of 12,270 patients that were in our study [1]-[32]. This is the largest study to date in the literature addressing diagnosis of COVID 19. Fever, cough and fatigue, in that respective order were the most common clinical symptoms. Laboratory findings consisted of leukopenia, elevated erythrocyte sedimentation (ESR) and elevated C-reactive protein, CRP. The gold standard test described in multiple studies was the RT-PCR. Serum assays of IgM and IgG were also drawn and found to be accurate in 93% of the time. CT Chest was both sensitive and specific, 90% and 86%. This diagnostic imaging was even more successful when coupled with clinical symptoms and approaching days 7 - 12 since the onset of clinical symptoms. Discussion: This is the largest study compiled to address diagnostic testing in COVID 19 patients. The patient population is spread vastly around the world, with access to many reported tests limited in certain countries. Given the significant sensitivity and specificity of diagnostic imaging, in the setting of clinical symptoms, we recommend patient undergo CT Chest in the face of COVID 19 exposure and clinical symptoms. While RT-PCR, IgM-IgG assays are beneficial, isolation, treatment, and possible quarantine of presumptive positive COVID 19 patients (based upon clinical symptoms and imaging) should not be delayed, for fear of increased infectivity and further risk to society at large.
机译:Covid 19引起了来自世界各地医疗保健实体的投降。首先在中国湖北描述,病毒已经蔓延到185个国家,表现出几乎没有根除或根除的迹象。绝对地存在医疗方案或疫苗来解决Covid 19。迄今为止,最佳反应是患者的早期诊断和立即隔离或检疫,并具有支持性护理。由于世界各地的医疗机构努力跟上这种大流行,在这种疾病实体的快速诊断中,医学专业人员并不是一项共识。目的:我们的研究目的是审查文献并建立一个测试或测试,这将有助于临床医生获得迅速,准确的诊断。方法:我们搜索了PubMed和Google Scholar并审核了32篇文章。关键字搜索包括Covid 19,大流行,诊断,诊断测试,众所周知。我们将从这些研究中获得的数据进行了比较,以努力寻找最佳诊断测试。结果:我们研究中共有12,270名患者[1] - [32]。这是迄今为止关于Covid 19的文献中的最大研究。发烧,咳嗽和疲劳,其各自的命令是最常见的临床症状。实验室调查结果由白细胞减少,升高的红细胞沉降(ESR)和升高的C反应蛋白,CRP。多项研究中描述的黄金标准测试是RT-PCR。还抽出IgM和IgG的血清测定,并发现93%的时间准确。 CT胸部敏感,特异性,90%和86%。当与临床症状加上临床症状以来,这种诊断成像更加成功,并且自临床症状开始以来。讨论:这是在Covid 19患者中解决诊断测试的最大研究。患者人口在全球范围内蔓延,可以访问许多据报道的某些国家的测试。鉴于诊断成像的显着灵敏度和特异性,在临床症状的设置中,我们建议患者在Covid 19接触和临床症状的面孔中接受CT胸部。在RT-PCR时,IgM-IgG测定是有益的,分离,治疗和可能的预防阳性Covid 19例的可治区(基于临床症状和成像),不应延迟,因为担心大量感染性和社会的进一步风险。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号